Clinical Trial: Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional



Official Title: A 3-Part Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Subcutaneous Ecallantide in Prepubertal Paediatric Patients Experiencing Acute Attacks of Hereditary Angi

Brief Summary:

The primary objective of this study is:

  • assess the safety and tolerability of ecallantide in paediatric patients for acute attacks of HAE

The secondary objectives are:

  • evaluate the pharmacokinetic profile of ecallantide in paediatric patients treated for acute attacks of HAE
  • assess the efficacy of ecallantide in paediatric patients treated for moderate to severe acute attacks of HAE